News

Filter

Current filters:

Renvela

1 to 9 of 22 results

Keryx' shares fall as FDA approves kidney drug, but with warnings

Keryx' shares fall as FDA approves kidney drug, but with warnings

07-09-2014

US drugmaker Keryx Biopharmaceuticals has received approval from the US Food and Drug Administration…

ferric citrateKeryx BiopharmaceuticalsNephrology and HepatologyPharmaceuticalRegulationRenvelaSanofiUSAZerenex

Chronic kidney disease market to witness slight decline by 2017

Chronic kidney disease market to witness slight decline by 2017

12-11-2013

The value of the chronic kidney disease market could drop 2.5% between 2012 and 2017 due to the loss…

EuropeFinancialGenzymeMarkets & MarketingNephrology and HepatologyPharmaceuticalRenagelRenvelaUSAZemplar Capsules

Impax Labs settles with Genzyme over Renvela and Renagel generics

05-09-2012

USA-based Impax Laboratories (Nasdaq: IPXL) says it has reached agreement with French drug major Sanofi's…

GenzymeImpax LaboratoriesPatentsPharmaceuticalRenagelRenvelaSanofi

Impax and Watson challenge Genzyme’s Renvela patent

05-07-2010

USA-based generic drugmaker Impax Laboratories has confirmed initiation of a challenge of a patent listed…

BiotechnologyGenericsGenzymeImpax LaboratoriesLegalNorth AmericaPatentsRenvelaWatson Pharmaceuticals

Strong generics sales see profit soar for IMPAX

06-05-2009

US drugmaker IMPAX Laboratories' profit rocketed for the first quarter of 2009, compared to the same…

DoryxDoxycyclineDoxycycline HyclateMonodoxOraceaRenvelaSevelamer Carbonate

1 to 9 of 22 results

COMPANY SPOTLIGHT

Menarini

Back to top